Health In Tech, Inc.

On March 14, 2025, the board of directors of the Company appointed Chris Kurtenbach, who served as the Company’s Senior Vice President of Operations from November 2024 to March 2025, to the position of Chief Operating Officer, effective on March 17, 2025. For the information required by Items 401(b) and (d) of Regulation S-K of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and for terms related to his employment agreement with the Company, see “Part III - Item 10 —Directors, Executive Officers and Corporate Governance” of this Annual Report on Form 10-K, the relevant portions of which are incorporated herein by reference.

There is no arrangement or understanding between Mr. Kurtenbach and any other person pursuant to which he was appointed as Chief Operating Officer. There are no family relationships between Mr. Kurtenbach and any of the Company’s directors, executive officers or persons nominated or chosen by the Company to become a director or executive officer of the Company. There are no transactions between Mr. Kurtenbach and the Company that would be required to be reported under Item 404(a) of Regulation S-K of the Exchange Act.

On March 14, 2025, the board of directors of the Company approved the replacement of (Jonathan) Del Lockett as Chief Operating Officer with Chris Kurtenbach as disclosed above, effective March 17, 2025. Mr. Lockett will continue to serve the Company as Chief Strategy Officer commencing on March 17, 2025. Mr. Lockett’s compensation will remain unchanged as a result of his new role as Chief Strategy Officer. This change in roles was not the result of any disagreement with the Company on any matter relating to its operations, policies or practices.